首页> 美国卫生研究院文献>Springer Open Choice >Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne®) in the CAM model
【2h】

Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne®) in the CAM model

机译:在CAM模型中对通过Verteporfin(Visudyne®)进行光动力疗法诱导的新血管闭塞进行视频监控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to monitor photodynamic angioocclusion with verteporfin in capillaries. Details of this process were recorded under a microscope in real-time using a high-sensitivity video camera. A procedure was developed based on intravenous (i.v.) injection of a light-activated drug, Visudyne®, into the chorioallantoic membrane (CAM) of a 12-day-old chicken embryo. The effect of light activation was probed after 24 h by i.v. injection of a fluorescent dye (FITC dextran), and analysis of its fluorescence distribution. The angioocclusive effect was graded based on the size of the occluded vessels, and these results were compared with clinical observations. The time-resolved thrombus formation taking place in a fraction of the field of view was video recorded using a Peltier-cooled CCD camera. This vessel occlusion in the CAM model was reproducible and, in many ways, similar to that observed in the clinical use of verteporfin. The real-time video recording permitted the monitoring of platelet aggregation and revealed size-selective vascular closure as well as some degree of vasoconstriction. Platelets accumulated at intravascular junctions within seconds after verteporfin light activation, and capillaries were found to be closed 15 min later at the applied conditions. Larger-diameter vessels remained patent. Repetition of these data with a much more sensitive camera revealed occlusion of the treated area after 5 min with doses of verteporfin and light similar to those used clinically. Consequently, newly developed light-activated drugs can now be studied under clinically relevant conditions.
机译:本研究的目的是监测维替泊芬在毛细血管中的光动力血管阻塞。使用高灵敏度摄像机在显微镜下实时记录该过程的细节。基于将光活化药物Visudyne ®静脉内(i.v.)注射到12天大的鸡胚的尿囊尿膜(CAM)中,开发了一种程序。 i.v.在24小时后探测了光激活的效果。注射荧光染料(FITC葡聚糖),并分析其荧光分布。根据闭塞血管的大小对血管闭塞作用进行分级,并将这些结果与临床观察结果进行比较。使用珀尔帖冷却的CCD摄像机录制了在一部分视场中发生的时间分辨的血栓形成。 CAM模型中的这种血管闭塞是可重现的,并且在许多方面与Verteporfin的临床使用中观察到的相似。实时视频记录允许监视血小板聚集并显示大小选择性的血管闭合以及一定程度的血管收缩。韦替泊芬光活化后数秒内,血小板在血管内连接处积聚,并在施加条件下15分钟后发现毛细血管关闭。大口径容器仍获得专利。用更灵敏的相机重复这些数据后,发现Verteporfin和光的剂量与临床使用的剂量相似,在5分钟后遮挡了治疗区域。因此,现在可以在临床相关条件下研究新开发的光活化药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号